home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

A Silent Killer

  November, 29 2005 11:37
your information resource in human molecular genetics
A mechanism that may selectively silence the electrical activity of dopamine producing neurons is suggested in a paper in December's Nature Neuroscience.

The slowed movements, rigidity and tremor in Parkinson's disease are caused by a reduction in the neurotransmitter dopamine, following the death of certain dopamine-producing neurons. What makes these neurons particularly vulnerable is not known, but this newly observed silencing could ultimately reduce their survival.

A common observation in Parkinson's disease and its animal models is reduced activity of the cell's power plants, the mitochondria, which produce energy in the form of a molecule called ATP. Birgit Liss and colleagues report that reduced levels of ATP decreased the electrical activity of the vulnerable neurons more strongly than in other neurons that do not die in the disease. The electrical silencing depended on an electrical current normally inhibited by ATP. Toxins that reduce mitochondrial function, which are used to produce animal models of Parkinson's disease, also silenced the vulnerable neurons. Compared to normal mice, mice genetically altered to lack the ATP-sensitive current showed less neuron death in response to these toxins. These results suggest that silencing of electrical activity in these neurons might contribute to their selective vulnerability in Parkinson disease and its animal models.

Author contact:

Birgit Liss (Marburg University, Marburg, Germany)
E-mail: birgit.liss@staff.uni-marburg.de

Abstract available online.

(C) Nature Neuroscience press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.